n-acetylmannosamine has been researched along with Disease Models, Animal in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cho, A; Hayashi, YK; Malicdan, MC; Mine, T; Nishino, I; Noguchi, S; Nonaka, I; Yamamoto, T; Yonekawa, T | 1 |
| Malicdan, MC; Nishino, I; Noguchi, S | 1 |
| Goto, Y; Hayashi, YK; Malicdan, MC; Nishino, I; Noguchi, S; Nonaka, I; Tokutomi, T | 1 |
| Ciccone, C; Darvish, D; Gahl, WA; Hoogstraten-Miller, S; Huizing, M; Kakani, S; Klootwijk, ED; Kopp, JB; Manoli, I; Niethamer, T; Poling, J; Ten Hagen, KG; Tian, E; Yardeni, T; Zerfas, P | 1 |
| Quaggin, SE | 1 |
| Ciccone, C; Darvish, D; Gahl, WA; Galeano, B; Hoffmann, VJ; Hoogstraten-Miller, S; Huizing, M; Klootwijk, R; Krasnewich, DM; Manoli, I; Starost, MF; Sun, M; Zerfas, PM | 1 |
1 review(s) available for n-acetylmannosamine and Disease Models, Animal
| Article | Year |
|---|---|
[Animal model of distal myopathy with rimmed vacuoles/hereditary inclusion body myopathy and preclinical trial with sugar compounds].
Topics: Administration, Oral; Animals; Disease Models, Animal; Distal Myopathies; Drug Evaluation, Preclinical; Hexosamines; Humans; Inclusion Bodies; Lactose; Mice; Mice, Transgenic; N-Acetylneuraminic Acid; Sialic Acids; Vacuoles | 2010 |
5 other study(ies) available for n-acetylmannosamine and Disease Models, Animal
| Article | Year |
|---|---|
Sialyllactose ameliorates myopathic phenotypes in symptomatic GNE myopathy model mice.
Topics: Aging; Amyloid beta-Peptides; Animals; Body Weight; Cells, Cultured; Creatine Kinase; Disease Models, Animal; Distal Myopathies; Enzyme-Linked Immunosorbent Assay; Hexosamines; Lactose; Mice; Muscle Contraction; Muscle, Skeletal; Mutation; Myoblasts; N-Acetylneuraminic Acid; Peptide Fragments; Phenotype | 2014 |
Peracetylated N-acetylmannosamine, a synthetic sugar molecule, efficiently rescues muscle phenotype and biochemical defects in mouse model of sialic acid-deficient myopathy.
Topics: Animals; Disease Models, Animal; Distal Myopathies; Hexosamines; Humans; Mice; Mice, Transgenic; Muscle, Skeletal; N-Acetylneuraminic Acid | 2012 |
The Gne M712T mouse as a model for human glomerulopathy.
Topics: Animals; Biomarkers; Carbohydrate Epimerases; Carrier Proteins; Dietary Supplements; Disease Models, Animal; Drug Evaluation, Preclinical; Hexosamines; Humans; Kidney Diseases; Kidney Glomerulus; Membrane Proteins; Mice; Mice, Mutant Strains; Microscopy, Electron; Mutation; N-Acetylneuraminic Acid; Podocytes; Real-Time Polymerase Chain Reaction; Sialoglycoproteins | 2012 |
Sizing up sialic acid in glomerular disease.
Topics: Animals; Disease Models, Animal; Female; Hexosamines; Humans; Kidney Diseases; Kidney Glomerulus; Mice; Mice, Mutant Strains; Models, Biological; Multienzyme Complexes; N-Acetylneuraminic Acid; Pregnancy | 2007 |
Mutation in the key enzyme of sialic acid biosynthesis causes severe glomerular proteinuria and is rescued by N-acetylmannosamine.
Topics: Animals; Base Sequence; Disease Models, Animal; DNA Primers; Female; Hexosamines; Humans; Kidney Diseases; Kidney Glomerulus; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Mice, Transgenic; Microscopy, Electron; Models, Biological; Multienzyme Complexes; N-Acetylneuraminic Acid; Pregnancy; Proteinuria | 2007 |